To determine whether harmine could enhance Bcl-2 antagonist-mediated apoptosis, we compared the effect of the Bcl-2 antagonist treatment with or without harmine on NSCLC cells. This evidence concerns the gene BCL2 and non-small cell lung carcinoma.